Autism Spectrum Disorder Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 40 years old
- People with an IQ above 70
- People who can read, write, and communicate effectively in English
- People who are able to give informed consent, as assessed by a clinician
- People with no history of seizures
- People who are willing to follow all study procedures and sign a consent form
- People who agree to avoid alcohol, tobacco, marijuana, and caffeine on the days of study visits
For people with Autism Spectrum Disorder (ASD), additional criteria apply:
- A formal ASD diagnosis under DSM-5 (a standard diagnostic system), without intellectual disability, confirmed through clinical assessment and a specific autism assessment tool called the ADOS-2
- Significant difficulties with movement or motor skills, as measured by a standardised motor skills test called the BOT-2
- Being medically stable with no changes to medication in the past four weeks
Who may not be able to join:
- People who are currently pregnant
- People with a current or past serious medical condition that may need urgent medical treatment
- People with a substance use disorder (other than tobacco) in the past six months
- People with significant hearing or vision problems that would make it difficult to follow instructions
- People with a serious neurological or medical illness, such as brain infections, brain tumours, aneurysms, or uncontrolled diabetes
- People with metal implants or a pacemaker
- People who have previously received a type of brain stimulation treatment called rTMS
- People with ASD who are currently taking benzodiazepines or anticonvulsant medications
For neurotypical (non-autistic) participants, additional exclusions apply:
- People who have a mental health condition other than a specific phobia, as identified through a screening assessment
- People who have a biological family member diagnosed with Pervasive Developmental Disorder or ASD
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 4165358501
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Changes in motor cortical plasticity using motor evoked potentials (MEPs) in autistic adults following rTMS.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.